Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the establishment of a new Center of Excellence (CoE) for Imaging Mass Cytometry™ (IMC™) in Singapore together with the Singapore Immunology Network (SIgN), part of the Agency for Science, Technology and Research (A*STAR).
